Table 2 Population outcomes

During ICU stay:

 - Vasopressor support, (day)^a

 - Mechanical ventilation, (day)^a

 - Renal replacement therapy, (n)

0 (0, 2)

8 (5, 12)

6

0 (0, 7)

7 (0, 14)

3

Organ support free days (day)^a

19 (12, 29)

8 (3, 11)

Secondary infection, (n(%))

8 (53.3%)

2 (33.3%)

Site of secondary infection (n = 10 (%)):

 - Pulmonary

 - Bloodstream

 - Other^b

4 (40.0%)

1 (10.0%)

3 (30.0%)

1 (10.0%)

1 (10.0%)

0

Length of ICU stay, including ICU readmission (day)*

16 (9, 32)

14 (9, 19)

Antibiotic consumption at day 29 or hospital discharge, (day)^a

20 (4, 29)

13 (11, 16)

Mortality at day 90, (n(%))

3 (20.0%)

2 (33.3%)